The maximum-well tolerated dose was established in this study, and subsequent clinical trials evaluating the efficacy of ZD4054 are being conducted based on these results.
A Phase III trial assessing docetaxel with or without ZD4054 is being undertaken in chemotherapy-naïve patients.